Literature DB >> 222892

Electroencephalographic and behavioral tolerance to and cross-tolerance between D-Ala2-methionine-enkephalinamide and morphine in the rat.

F C Tortella, J E Moreton, N Khazan.   

Abstract

Rats were given repeated intraventricular (i.vt.) injections of D-enkephalin (20 microgram/4 hr) or morphine (20 microgram/4 hr) for 72 to 96 hr during electroencephalograman(EEG) recording. Initial epileptiform EEG and associated wet-dog shakes occurred following D-enkephalin but not morphine. The epileptoid EEG progressed to a continous high-voltage EEG synchrony similar to morphine and was associated with behavioral stupor. Rapid eye movement sleep was also suppressed. Repeated administration of D-enkephalin or morphine produced tolerance to their effects. When challenged with i.vt. morphine, D-enkephalin-tolerant rats were cross-tolerant to morphine. Likewise, morphine-tolerant rats were cross-tolerant to D-enkephalin. While the morphine-tolerant rats demonstrated a marked abstinence syndrome when challenged with naloxone (10 mg/kg i.p.), no abstinence signs were observed in the D-enkephalin-tolerant rats. The demonstration of tolerance and cross-tolerance between morphine and D-enkephalin suggests a similar mechanism of action, but the differential development of physical dependence may entail different mechanisms or receptor sensitivities for this effect. These findings of similarities and differences in the acute and chronic effects of D-enkephalin and morphine support the contention that heterogenous opiate receptors may mediate their pharmacologic actions.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 222892

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  5 in total

1.  Biphasic effects of chronic saccharin intake on pain responses of healthy and diabetic rats of two genetically selected strains.

Authors:  F Bergmann; E Cohen; I Lieblich
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

2.  Opioidergic projections to sleep-active neurons in the ventrolateral preoptic nucleus.

Authors:  Mary-Ann Greco; Patrick M Fuller; Thomas C Jhou; S Martin-Schild; James E Zadina; Zhian Hu; Priyattam Shiromani; Jun Lu
Journal:  Brain Res       Date:  2008-09-24       Impact factor: 3.252

3.  Morphine inhibits sleep-promoting neurons in the ventrolateral preoptic area via mu receptors and induces wakefulness in rats.

Authors:  Qin Wang; Xiao-Fang Yue; Wei-Min Qu; Rong Tan; Ping Zheng; Yoshihiro Urade; Zhi-Li Huang
Journal:  Neuropsychopharmacology       Date:  2012-11-30       Impact factor: 7.853

4.  D-ala2-methionine-enkephalinamide self-administration in the morphine-dependent rat.

Authors:  F C Tortella; J E Moreton
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

5.  Similarities and differences between D-ALA2 MET5 enkephalin amide and morphine in the induction of tolerance to their effects on catalepsy and on dopamine metabolism in the rat brain.

Authors:  M G De Simoni; V Guardabasso; K Misterek; S Algeri
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-11       Impact factor: 3.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.